The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/5 fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers (DOC-GC study).
 
Anant Ramaswamy
No Relationships to Disclose
 
Prabhat Ghanshyam Bhargava
Honoraria - Intas (Inst); Merck (Inst)
Consulting or Advisory Role - Lupin Pharmaceuticals (Inst); Mankind Pharma (Inst)
Speakers' Bureau - Novartis (Inst); Zydus Pharmaceuticals (Inst)
 
Biswajit Dubashi
No Relationships to Disclose
 
Akhil Kapoor
Research Funding - AstraZeneca (Inst); Bayer (Inst); Biocon (Inst); Lilly (Inst); Novartis (Inst)
 
Sujay Srinivas
Honoraria - AstraZeneca
 
Omshree Shetty
No Relationships to Disclose
 
Rajiv Kumar Kaushal
No Relationships to Disclose
 
Aekta Shah
No Relationships to Disclose
 
Vanita Noronha
Research Funding - Dr. Reddy's Laboratories (Inst); Intas (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Amit Joshi
No Relationships to Disclose
 
Nandini Sharrel Menon
No Relationships to Disclose
 
Chaitali Nashikkar
No Relationships to Disclose
 
Anuj Gupta
No Relationships to Disclose
 
Bal Krishna Mishra
No Relationships to Disclose
 
Smita Kayal
No Relationships to Disclose
 
Ramesh Ananthakrishnan
No Relationships to Disclose
 
Suman Kumar
No Relationships to Disclose
 
Prasanth Ganesan
Research Funding - Alkem Laboratories (Inst); Johnson & Johnson/Janssen (Inst)
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); NATCO Pharma (Inst); Roche (Inst)
 
Vikas S. Ostwal
Research Funding - BDR Pharmaceutics (Inst); Cadila Pharmaceuticals (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Lupin Pharmaceuticals (Inst); NATCO Pharma (Inst); Panacea Pharmaceuticals (Inst); Panacea Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; NATCO Pharma; NATCO Pharma